Thanks for the article. Again, the author had a converging comment that the cost is one of the main reasons pushed patients to cheaper or less effective regimes which has been raised by colleagues here. The focus should be on making the antivenoms more affordable.
HIFA profile: Chris [Kam-wa Chan] received training in basic science, biomedical science, clinical Chinese medicine and public health from the University of Hong Kong, Hong Kong Baptist University and London School of Hygiene & Tropical Medicine. He is currently a research clinician based in Hong Kong and has been actively engaged in clinical medicine, clinical trials, basic science research and qualitative research. He had served for Hospital Authority, World Health Organisation, KPMG Advisory and hospitals on research consultancy, medical administration and clinical medicine in Hong Kong and mainland China before his academic engagement.